Actinogen Medical Limited (FRA:3AC)

Actinogen Medical Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 28, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	106	41	104	44	59	137
Market Cap Growth	122.40%	-60.62%	133.88%	-25.15%	-56.65%	806.03%
Enterprise Value	98	28	96	36	45	129
Last Close Price	0.03	0.01	0.04	0.01	0.02	0.06
PS Ratio	34.45	13.31	16.75	14.86	24.67	108.80
PB Ratio	10.31	3.99	8.45	5.42	4.13	12.37
P/TBV Ratio	11.42	4.41	9.45	6.61	4.72	14.97
EV/Sales Ratio	31.72	9.20	15.60	11.93	18.61	102.47
Debt / Equity Ratio	0.18	0.18	0.02	0.01	0.01	0.01
Asset Turnover	0.24	0.24	0.54	0.25	0.18	0.13
Quick Ratio	3.74	3.74	13.83	6.99	13.73	19.87
Current Ratio	3.76	3.76	13.91	7.04	13.80	19.99
Return on Equity (ROE)	-77.47%	-77.47%	-78.81%	-61.18%	-48.46%	-27.62%
Return on Assets (ROA)	-41.91%	-41.91%	-45.37%	-35.65%	-28.59%	-16.16%
Return on Capital (ROIC)	-46.12%	-46.12%	-49.45%	-38.79%	-30.09%	-16.91%
Return on Capital Employed (ROCE)	-82.90%	-82.90%	-66.40%	-81.90%	-43.70%	-22.20%
Earnings Yield	-7.79%	-20.16%	-7.84%	-14.80%	-10.58%	-1.81%
FCF Yield	-4.02%	-10.39%	-10.20%	-12.02%	-10.60%	-0.80%
Buyback Yield / Dilution	-37.04%	-37.04%	-20.69%	-4.92%	-22.20%	-25.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.